New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 21, 2014
10:31 EDTNIHD, FL, LCI, BBT, CROX, SIAL, EZPW, EXTR, OREX, STLDHigh option volume stocks:
High option volume stocks: EZPW LCI STLD SIAL FL OREX CROX NIHD EXTR BBT
News For EZPW;LCI;STLD;SIAL;FL;OREX;CROX;NIHD;EXTR;BBT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
December 19, 2014
10:39 EDTFLNike leads footwear space lower after futures growth slows
Subscribe for More Information
10:02 EDTFLFoot Locker downgraded to Underperform from Neutral at BofA/Merrill
Subscribe for More Information
09:28 EDTOREXOn The Fly: Pre-market Movers
Subscribe for More Information
07:21 EDTOREXOrexigen Mysimba receives positive CHMP opinion
Subscribe for More Information
07:20 EDTOREXOrexigen weight loss drug recommended in Europe
The European Medicines Agency's Committee for Medicinal Products for Human Use recommended granting a marketing authorization for Mysimba for weight management of overweight or obese adults. The medicine is recommended for use in addition to a reduced-calorie diet and physical activity. Mysimba is made by Orexigen.
December 18, 2014
13:21 EDTLCILannett receives FDA approval for Dorzolamide HCL with Timolol
Lannett announced that it has received approval from the U.S. FDA of its Abbreviated New Drug Application for Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution, 2%/0.5%, the therapeutic equivalent to the reference listed drug, Cosopt Ophthalmic Solution, 2%/0.5%, of Oak Pharmaceuticals, Inc.. According to IMS, for the year ended October 2014 total sales of Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution, 2%/0.5%, at Average Wholesale Price were approximately $123M.
December 17, 2014
18:02 EDTSTLDSteel Dynamics sees Q4 EPS ex-items 38c-42c, consensus 45c
Subscribe for More Information
December 16, 2014
09:59 EDTBBTOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: BB&T (BBT) initiated with a Neutral at Guggenheim... Bank of America (BAC) initiated with a Buy at Guggenheim... Ciena (CIEN) initiated with a Neutral at Wedbush... Cimarex Energy (XEC) initiated with a Perform at Oppenheimer... Citigroup (C) initiated with a Neutral at Guggenheim... Extended Stay America (STAY) initiated with a Market Perform at JMP Securities... Infinera (INFN) initiated with a Neutral at Wedbush... JPMorgan (JPM) initiated with a Neutral at Guggenheim... Morgan Stanley (MS) initiated with a Buy at Guggenheim... Newfield Exploration (NFX) initiated with an Outperform at Oppenheimer... Nike (NKE) initiated with a Market Perform at Cowen... PNC Financial (PNC) initiated with a Neutral at Guggenheim... Peak Resorts (SKIS) initiated with an Outperform at FBR Capital... Peak Resorts initiated with an Outperform at Oppenheimer... Ralph Lauren (RL) initiated with an Outperform at Cowen... U.S. Bancorp (USB) initiated with a Neutral at Guggenheim... Under Armour (UA) initiated with an Outperform at Cowen... Wells Fargo (WFC) initiated with a Neutral at Guggenheim... Whiting Petroleum (WLL) initiated with an Outperform at Oppenheimer... Lowe's (LOW) initiated with a Neutral at Nomura... Home Depot (HD) initiated with a Neutral at Nomura... Estee Lauder (EL) initiated with a Buy at KeyBanc... Huntsman (HUN) initiated with a Buy at Nomura... Dow Chemical (DOW) initiated with a Buy at Nomura.
09:59 EDTCROXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:31 EDTCROXCrocs upgraded at Sterne Agee
Subscribe for More Information
08:11 EDTCROXCrocs new CEO positive, says Stifel
Subscribe for More Information
07:03 EDTCROXCrocs upgraded to Buy from Neutral at Sterne Agee
Price target is $16.
December 15, 2014
16:36 EDTCROXCrocs names Gregg Ribatt as CEO
Subscribe for More Information
16:12 EDTBBTBB&T initiated with a Neutral at Guggenheim
10:10 EDTOREXHigh option volume stocks:
High option volume stocks: RVBD AGCO FRO CRUS UBNT LH PAY PETM OREX KOS
December 12, 2014
08:09 EDTBBTBofA/Merrill financial analysts hold an analyst/industry conference call
Banks Analyst Najarian, along with Capital Markets Analyst Carrier, Specialty Finance Analyst Bruce discuss the year ahead in Financials, covering the Banks, Capital Markets, Life and P/C Insurance, REIT, Specialty Finance and Canadian Banks/Life Insurance sectors on an Analyst/Industry conference call to be held on December 16 at 10 am.
December 10, 2014
10:44 EDTBBTBB&T CEO says managing expenses in this environment 'really hard'
BB&T (BBT) says sees consumer, business confidence improving in 2015. Expects that 2015 will not be a "break out" year. Says still challenges to increase revenue in U.S. market. Says long-term goals include: Less-volatile results, growing dividends, capital return, growing share price. Sees "solid" revenue year in 2015, will remain "intensely focused" on expenses. Says managing expenses in this environment "really hard." Says "well prepared" to successfully execute on Susquehanna (SUSQ) acquisition. Says feels "substantially" better about global economy than last year, though notes that it has eroded "some" since last year in certain regions. Says regulators feeling "more comfortable with where banks are." Says dividends "really important" to company. Says capital request to be substantially higher in 2015, likely in the 60% range. Says not chasing growth for growth's sake. BB&T CEO Kelly King is presenting at the Goldman Sachs U.S. Financial Services Conference.
December 8, 2014
17:34 EDTLCILannett served with subpoena in federal probe related to generic industry
Subscribe for More Information
11:30 EDTLCILeerink generics pharmaceutical analyst holds analyst/industry conference call
Subscribe for More Information
08:33 EDTEXTRExtreme Networks and IMG form strategic partnership
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use